Johnson & Johnson reported a 25% drop in earnings and declining sales for the fourth quarter as demand dropped for its Covid-19 vaccine, while providing a cautious forecast for sales growth as the company undergoes a big transformation.
The New Brunswick, N.J., healthcare-products company said Tuesday that quarterly revenue fell 4.4% to $23.71 billion on fewer vaccine sales and a stronger dollar, below analyst estimates of $23.9 billion, according to FactSet.
Italia Ultime Notizie, Italia Notizie
Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.
Microsoft Earnings Likely Slid Last Quarter Amid Economic ConcernsThe software giant likely recorded its slowest sales growth in more than six years last quarter as economic concerns cooled demand for its software and cloud services. That's because they did what was once thought impossible, they released a Windows that was worse than Windows 8. 😬😬😬
Leggi di più »